EUVIMEDEUVIMED entdecken
Crossref

The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application

Chang-Hun Jung

Aging Pathobiology and Therapeutics · 25.06.2026 · 8 (2)

DOI: 10.31491/apt.2026.06.227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, online erschienen am 30.06.2026. Verfasst von Chang-Hun Jung.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jung, C. (2026). The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application. Aging Pathobiology and Therapeutics, 8(2). https://doi.org/10.31491/apt.2026.06.227

Vancouver

Jung C. The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application. Aging Pathobiology and Therapeutics. 2026;8(2). doi:10.31491/apt.2026.06.227

BibTeX
@article{Jung2026,
  author = {Jung, Chang-Hun},
  title = {The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application},
  journal = {Aging Pathobiology and Therapeutics},
  year = {2026},
  volume = {8},
  number = {2},
  doi = {10.31491/apt.2026.06.227}
}
Kostenlos starten →